Navigation Links
Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Month's Supply of New Product Immediately and on Track to Ensure Sustainable Supply
Date:2/21/2012

ablishing safety stock to ensure patients and families never have to face this type of fear again.

"I specifically want to commend Commissioner Hamburg and the efforts by FDA's Center for Drugs and the Drug Shortage Program, led by Dr. Sandra Kweder and Captain Valerie Jensen, for the Agency's rapid response to the methotrexate shortage and for their tireless efforts to help address the challenges of drug shortages overall. Hospira supports, and has been providing, early warning notification to the Agency, and we believe this is a necessary step in our continued collaboration to prevent drug shortages. I also want to commend the members of Congress who have rallied support and pledged their commitment to combat drug shortages and the serious burden they place on patients and families.

"As everyone gathered here today knows, drug shortages in general have been a widespread and serious issue. Hospira is taking action to address shortages by investing hundreds of millions of dollars to increase capacity at existing facilities, build additional capacity and improve our manufacturing plants. We take our responsibility to this country and our patients seriously, and we look forward to working with key stakeholders to help prevent future shortages and avoid these types of frightening situations from recurring.

"Commissioner, we thank you for this opportunity, and on behalf of our 15,000 employees who are dedicated to the hospitals, healthcare providers, patients and families who need our products, we look forward to continuing our work with you to stop drug shortages."

Earlier today, the FDA issued a press release on progress addressing the methotrexate shortage. The press release can be accessed at the following link: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm292658.htm

About Hospira
Hospi
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
2. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
3. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
4. Hospira Reports Third-Quarter 2011 Results
5. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
6. Hospira to Host Conference Call for Third-Quarter 2011 Results
7. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
8. Hospira to Host 2011 Investor Day
9. Hospira to Present at the Morgan Stanley Global Healthcare Conference
10. Hospira Expands Board of Directors
11. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), an innovator and ... breathing and other chronic respiratory conditions, has won a ... Taiwanese medical device manufacturer APEX Medical Corp. (APEX), prohibiting ... and 220 masks.  The judgment was entered by the ... is appealable, and applies throughout Germany.  ...
(Date:7/28/2014)... -- ANI Pharmaceuticals, Inc. (NASDAQ: ANIP ) announced ... quarter and year-to-date 2014 financial results on Monday, August ... markets. The earnings press release will be accessible through ... www.anipharmaceuticals.com . Arthur S. Przybyl , ... Arnold , Vice President and Chief Financial Officer, also ...
Breaking Medicine Technology:TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2
... announces that a new market research report is ... Global Medical Ultrasound Equipment Industry ... analyzes the worldwide markets for Medical Ultrasound Equipment ... segments: Radiology, Cardiology, Obstetrics/Gynecology, Vascular, and Other (Other ...
... announces that a new market research report is ... Iodine Industry http://www.reportlinker.com/p0397812/Global-Iodine-Industry.html ... markets for Iodine in Metric Tons by the ... Human Health, Stabilizers, Optical Polarizing Film (OPF), and ...
Cached Medicine Technology:Reportlinker Adds Global Medical Ultrasound Equipment Industry 2
(Date:7/28/2014)... (BUSM) report variants in a new gene, PLXNA4, which ... The discovery of this novel genetic association may lead ... These findings appear in the Annals of Neurology ... affecting 5.4 million Americans including 13 percent of people ... of people age 85 and older. Genetic factors account ...
(Date:7/28/2014)... The University of Texas Health Science Center at San Antonio, ... combination of pills that cures 9 of 10 hepatitis C ... with or without ribavirin, cured 93 percent of patients in ... the study published today in The Lancet . ... Eric Lawitz, M.D., clinical professor in the School of Medicine ...
(Date:7/28/2014)... The Wireline Services Market in Europe report defines ... and forecast of revenue. The Wireline services market in Europe ... to $2.4 billion by 2019, at a CAGR of 11.2%, ... the Wireline Services Market in Europe report, to get an ... glimpse of the segmentation in the European Wireline Services market, ...
(Date:7/28/2014)... The North America Carotenoids & Antioxidants Market report defines ... with analysis and forecast of revenue. This market is estimated ... million by 2018, at a CAGR of 7.1% from 2013 ... America Carotenoids & Antioxidants Market report to get an idea ... of the segmentation in the market, and is supported by ...
(Date:7/28/2014)... A common inflammatory muscle disorder that causes pain ... risk for heart attack and stroke, new ... patients with polymyalgia rheumatica are more likely to ... blood vessels. Doctors should carefully manage the vascular ... reduce their risk for complications, the study authors ...
Breaking Medicine News(10 mins):Health News:Researchers identify potential biomarker for AD 2Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $812.7 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Inflammatory Muscle Disorder May Raise Risk for Heart Attack, Stroke 2
... Relationship Expected to Result in Improved Nursing Productivity in the ... ... Panama City, Fla. (PRWEB) February 27, 2009 -- iSirona®, an ... announced that it has signed an agreement with NxStage Medical, ...
... proud to announce the launch of searchjointpain.com, a new informational Web site ... , ... Potomac, MD (PRWEB) February 27, 2009 -- The Healthy Living Network, ... of searchjointpain.com , a new informational Web site devoted to all ...
... MS treatment; more than 130 clinical trials are under way. ... ... patients with multiple sclerosis is gaining traction through a number of ... Sclerosis Society , which is celebrating National MS Awareness Week on ...
... commitment to marketing spend Hallmark Cards today unveiled its plans for a ... ,Cards For A Cure™, campaign. This will be the third year ... to two breast cancer charities by the end of its 2009 Mother,s ... ...
... Leading heath insurance fund Medibank Private has released a list of the ... ... February 27, 2009 -- A hospital bill of $364,859 for complex bowel ... expensive health insurance benefit claims made by members of the ...
... Woman,s Measurements , New web-based research has quantified the ... researchers manipulated the features of one woman into 243 ... hip and waist widths. Then more than 34,000 people ... face remained exactly the same in all of the ...
Cached Medicine News:Health News:iSirona Signs Reference Selling Agreement with NxStage 2Health News:Healthy Living Network Announces Launch of New Joint Pain Web Site 2Health News:MS Research, Funding Speed Development of New Therapies 2Health News:Hallmark Cards Increases Investment In Cards For a Cure™ with Major Advertising and PR Campaign for Mother's Day 2009 2Health News:Hallmark Cards Increases Investment In Cards For a Cure™ with Major Advertising and PR Campaign for Mother's Day 2009 3Health News:Health Insurance Claims Top $2 Million Mark 2Health News:Health Insurance Claims Top $2 Million Mark 3Health News:Plastic and reconstructive surgery ... in brief 2
... IOL with OptiEdge offers design innovations that ... and excellent handling. The biostable acrylic material ... of vacuoles; the patented OptiEdge is designed ... 360 degrees of contact with the posterior ...
... an intraocular lens that doesn't stop ... natural human lens, the new ACRYSOF® ... high-energy blue light. But while it ... your patient's view. That's just as ...
Single-Piece PMMA Intraocular Lenses....
Single-Piece PMMA Intraocular Lenses....
Medicine Products: